On Monday, Werewolf Therapeutics Inc (NASDAQ: HOWL) was -5.06% drop from the session before settling in for the closing price of $0.65. A 52-week range for HOWL has been $0.56 – $2.38.
Healthcare Sector giant saw their annual sales slid by -20.76% over the last five years. When this article was written, the company’s average yearly earnings per share was at 7.24%. With a float of $38.86 million, this company’s outstanding shares have now reached $47.27 million.
Werewolf Therapeutics Inc (HOWL) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Werewolf Therapeutics Inc stocks. The insider ownership of Werewolf Therapeutics Inc is 19.94%, while institutional ownership is 29.84%. The most recent insider transaction that took place on Dec 29 ’25, was worth 66,250. In this transaction Director of this company sold 108,606 shares at a rate of $0.61, taking the stock ownership to the 2,550,674 shares. Before that another transaction happened on Dec 23 ’25, when Company’s Director sold 71,428 for $0.63, making the entire transaction worth $45,000. This insider now owns 2,711,222 shares in total.
Werewolf Therapeutics Inc (HOWL) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.46 earnings per share (EPS) during the time that was less than consensus figure (set at -0.31) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.89% during the next five years compared to -20.76% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
You can see what Werewolf Therapeutics Inc (HOWL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.47 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
Analysing the last 5-days average volume posted by the [Werewolf Therapeutics Inc, HOWL], we can find that recorded value of 1.04 million was better than the volume posted last year of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 13.49%.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 3.43%, which indicates a significant decrease from 9.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0885 in the past 14 days, which was lower than the 0.1224 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0933, while its 200-day Moving Average is $1.2059. Now, the first resistance to watch is $0.6511. This is followed by the second major resistance level at $0.6811. The third major resistance level sits at $0.7121. If the price goes on to break the first support level at $0.5901, it is likely to go to the next support level at $0.5591. Should the price break the second support level, the third support level stands at $0.5291.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
There are 48,540K outstanding shares of the company, which has a market capitalization of 30.15 million. As of now, sales total 1,890 K while income totals -70,520 K. Its latest quarter income was 0 K while its last quarter net income were -16,370 K.
